Who founded Ilico Genetics?

Ilico Genetics was founded by Alejandro Corvalán in 2020.

Who are Ilico Genetics's investors?

Ilico Genetics's investors include Life Sciences Greenhouse Investments.

Where is Ilico Genetics headquartered?

Ilico Genetics is headquartered in Santiago, CL.

Ilico Genetics

Santiago, CL · Founded 2020 · 5 employees on LinkedIn · 2 known investors

Find your way into Ilico Genetics

391 people in our graph share verified history with the Ilico Genetics team — schools, employers, funds. One of them is your warm intro.

Lauren Arribasunlockedknows Fernando Alarcon · together at The Wharton School (overlapped)

knows the team · via Villanova University

×4knows the team · via The Wharton School

×2knows the team · via Pontificia Universidad Católica de Chile

knows the team · via Colliers International | Chile

knows the team · via MD Anderson Cancer Center

Ilico Genetics develops a blood-based molecular test for the early detection of gastric cancer using methylated DNA markers, designed to identify disease years before traditional methods. The company serves gastroenterologists and patients in the oncology diagnostics space, with a platform technology applicable to precision medicine and disease prevention.

Biotech Healthtech Medical Devices

Founders & leadership

Ilico Genetics was founded in 2020 by Alejandro Corvalán.

Alejandro Corvalán inMDMD with degrees from Universidad de Chile and ECFMG certification; previously worked as a pathologist at Mount Sinai School of Medicine and postdoctoral fellow in molecular pathology at Tokyo Medical and Dental School and Kagoshima University. Currently Full Professor and Principal Investigator at the Advanced Center for Chronic Diseases at Pontificia Universidad Católica de Chile, conducting translational research on gastric cancer molecular biology.

Fernando Alarcon inMBAFernando Alarcon has a background in corporate finance and M&A advisory across Latin America, working on valuations, capital raises, and growth strategy in healthcare and pharma sectors. He is co-founder of Ilico Genetics, which develops a blood-based molecular test using methylated DNA markers to detect gastric cancer early in high-risk patients.

Maria J. MaturanainMSc

Investors · 2

Life Sciences Greenhouse InvestmentsHarrisburg · $250K – $500K

Also in the syndicate · 1

Life Science Greenhouse Investments

Funding

SEC filings, press & company announcements

Undisclosed amountSAFE roundSep 2023
Life Science Greenhouse Investments
Source ↗

▶$457.7KraisedOct 2023 · 10 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Maria Jose Maturana RojasDirector
Alejandro Hernan Corvalan RodriguezDirector
Fernando A Alarcon HardyExecutive Officer, Director

Amount sold: $457.7K
Proceeds to insiders: $75K
First sale: Jan 2023
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

LSGI INVESTS >$238K IN ILICO GENETICS — LSG Investmentslsgpa.com · Sep 2023

Frequently asked questions

What does Ilico Genetics do?: Ilico Genetics develops a blood-based molecular test for the early detection of gastric cancer using methylated DNA markers, designed to identify disease years before traditional methods. The company serves gastroenterologists and patients in the oncology diagnostics space, with a platform technology applicable to precision medicine and disease prevention.
Who founded Ilico Genetics?: Ilico Genetics was founded by Alejandro Corvalán in 2020.
Who are Ilico Genetics's investors?: Ilico Genetics's investors include Life Sciences Greenhouse Investments.
Where is Ilico Genetics headquartered?: Ilico Genetics is headquartered in Santiago, CL.